Priority Date: 07.03.11 (EP 20110157229)

USE OF APTAMERS IN THERAPY AND/OR DIAGNOSIS OF AUTOIMMUNE DISEASES

  • Application ID: EP12711799
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorneys

Employment test 11 - 50 employees
Company dna gulde hengelhaupt ziebig and schneider
operating since 1990
Headquarter in Berlin and 6 offices
active in Legal Services and IP Consulting
Employment test 11 - 50 employees
Company dna westendrop sommer
operating since 2009
Headquarter in Munich and 1 office
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 174 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 07.03.2011 - Priority Date (EP 20110157229)
  • 13.09.2012 - Publication A2 (WO2012119938)
  • 15.01.2014 - Publication A2 (EP2683826)
  • 08.06.2016 - Publication B1 (EP2683826)

IPC Classification